as on September 17, 2025 at 1:29 am IST
Day's Low
Day's High
0.68%
Downside
0.48%
Upside
52 Week's Low
52 Week's High
9.58%
Downside
47.24%
Upside
Check Merck & Co. Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$202.5B
EPS (TTM)
8.9313
Dividend Yield
2.56%
Quarterly Earnings Growth YOY
-0.18%
PE Ratio (TTM)
12.49
Industry PE ratio
17.391111111111112
P/B Ratio
12.4946
PEG Ratio
0.7258
EBITDA
28.3B
Revenue (TTM)
63.6B
Profit Margin
25.79%
Return On Equity TTM
35.42%
Track how Merck & Co. Inc. P/E has moved over time to understand its valuation trends.
Merck & Co. Inc. in the last 5 years
Lowest (10.40x)
June 30, 2025
Today (12.49x)
September 17, 2025
Industry (17.39x)
September 17, 2025
Highest (69.20x)
December 31, 2023
Today’s Price to Earnings Ratio: 12.49x
Compare market cap, revenue, PE, and other key metrics of Merck & Co. Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $202.5B | -5.31% | 12.49 | 25.79% | |
BUY | $685.5B | 390.71% | 49.02 | 25.91% | |
BUY | $382.0B | 141.28% | 102.98 | 6.45% | |
BUY | $240.9B | 59.9% | 14.01 | 35.61% | |
BUY | $425.0B | 19.9% | 18.91 | 25.00% |
The Merck & Co. Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Merck & Co. Inc. investment value today
Current value as on today
₹73,142
Returns
Returns from Merck & Co. Inc. Stock
Dollar Returns*
₹4,598 (+4.6%)
Based on 31 analysts
87.10%
Buy
12.90%
Hold
0.00%
Sell
Based on 31 analysts, 87.1% of analysts recommend a 'BUY' rating for Merck & Co. Inc.. Average target price of $102.33
Get share price movements and forecasts by analysts on Merck & Co. Inc..
What analysts predicted
20.77%UPSIDE
Target Price
$102.33
Current Price
$81.08
Analyzed by
31 Analysts
Target
$102.33
Merck & Co. Inc. target price $102.33, a slight upside of 20.77% compared to current price of $81.08. According to 31 analysts rating.
Investment in Merck & Co. Inc. Shares on INDmoney has grown by 2.75% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:2.75%Â versus previous 30 day period
Search interest for Merck & Co. Inc. Stock has increased by 2% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:2%Â versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Check out the Mutual Funds with significant holdings in Merck & Co. Inc..
Today's Timeline - 16 September
Tue, 07:31 PM
-Merck plans acquisition of Verona Pharma to strengthen its portfolio and pipeline amid market challenges.
Tue, 08:49 PM
-Merck and Daiichi Sankyo receive FDA Breakthrough Therapy Designation for R-DXd, targeting specific cancers.
Wed, 00:28 AM
-Analysts maintain bullish stance on Merck, citing strong pipeline and strategic position in antibody-drug conjugates.
Today's Timeline - 16 September
Wed, 01:52 AM
-Investor Nygren expresses bullish outlook on Merck's diverse assets, including vaccines and animal health.
Wed, 02:12 AM
-Merck's shares underperform due to competitive pressures, but Keytruda and new products drive sales growth.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Merck & Co. Inc. has shown positive revenue performance over the last two quarters. The company's revenue increased from $15.52 billion to $15.80 billion, reflecting an average growth of 1.8% per quarter.
Against Peers
In the last 3 years, Eli Lilly And Company has given 50.1% return, outperforming this stock by 57.7%
Against Peers
In the last 1 year, Abbvie Inc has given 11.8% return, outperforming this stock by 43.2%
Profit Down
Merck & Co. Inc. has experienced a decline in its net profit over the last two quarters. The company's net profit dropped from $5.07 billion to $4.42 billion, averaging a decrease of 12.8% per quarter.
Price Dip
In the last 7 days, MRK stock has moved down by -3.5%
Organisation | Merck & Co. Inc. |
Headquarters | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 |
Industry | Health Technology |
CEO | Mr. Robert M. Davis J.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Robert M. Davis J.D. | Chairman, President & CEO |
Mr. Peter Dannenbaum | Vice President of Investor Relations |
Ms. Jennifer L. Zachary J.D. | Executive VP & General Counsel |
Mr. Dalton E. Smart III | Senior VP of Finance, Principal Accounting Officer & Global Controller |
Mr. David Michael Williams | Executive VP and Chief Information & Digital Officer |
Ms. Cristal N. Downing | Executive VP and Chief Communications & Public Affairs Officer |
Ms. Caroline A. Litchfield | Executive VP & CFO |
Ms. Betty D. Larson | Executive VP & Chief Human Resources Officer |
Mr. Richard R. DeLuca Jr. | Executive VP & President of Merck Animal Health |
Dr. Dean Y. Li M.D., Ph.D. | Executive VP & President of Merck Research Laboratories |
Merck & Co. Inc. share price today is $81.08 as on at the close of the market. Merck & Co. Inc. share today touched a day high of $81.47 and a low of $80.53.
Merck & Co. Inc. share touched a 52 week high of $119.38 on and a 52 week low of $73.31 on . Merck & Co. Inc. stock price today i.e. is closed at $81.08,which is 32.08% down from its 52 week high and 10.60% up from its 52 week low.
Merck & Co. Inc. market capitalisation is $0.20T as on .
Indian investors can start investing in Merck & Co. Inc. (MRK) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Merck & Co. Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Merck & Co. Inc. share’s latest price of $81.08 as on September 17, 2025 at 1:29 am IST, you will get 0.1233 shares of Merck & Co. Inc.. Learn more about
fractional shares .
Merck & Co. Inc. stock has given -5.31% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?